Midatech Pharma Plc (MTPH):企業の財務・戦略的SWOT分析

◆英語タイトル:Midatech Pharma Plc (MTPH) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14943
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The company’s products include gelclair, oravig, soltamox and zuplenz. It conducts research and development programs in the areas of oncology, autoimmune diseases, pipeline, Q-octreotide, opsisporin, HCC, glioblastoma and diabetes vaccine. Midatech’s products are used in treatment of diabetes; rare cancers including brain, ovarian, liver and pancreatic cancer and neurological and ophthalmologic conditions. It collaborates with universities, and specialty and major pharmaceutical companies to develop its platform technologies. The company operates through its manufacturing facility in Bilbao, and research facility in Cardiff. Midatech is headquartered in Abingdon, the UK.

Midatech Pharma Plc Key Recent Developments

Feb 25,2019: Midatech Pharma: Board changes
Jul 25,2018: Midatech Pharma: Trading update
Jun 01,2018: Midatech Pharma: Board change
Apr 23,2018: Midatech Pharma: Audited financial results for the year ended 31 December 2017
Mar 15,2018: Midatech announces changes in Senior Management Team

This comprehensive SWOT profile of Midatech Pharma Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Midatech Pharma Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Midatech Pharma Plc – Key Information
Midatech Pharma Plc – Overview
Midatech Pharma Plc – Key Employees
Midatech Pharma Plc – Key Employee Biographies
Midatech Pharma Plc – Key Operational Heads
Midatech Pharma Plc – Major Products and Services
Midatech Pharma Plc – History
Midatech Pharma Plc – Company Statement
Midatech Pharma Plc – Locations And Subsidiaries
Midatech Pharma Plc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Midatech Pharma Plc – Business Description
Midatech Pharma Plc – Corporate Strategy
Midatech Pharma Plc – SWOT Analysis
SWOT Analysis – Overview
Midatech Pharma Plc – Strengths
Midatech Pharma Plc – Weaknesses
Midatech Pharma Plc – Opportunities
Midatech Pharma Plc – Threats
Midatech Pharma Plc – Key Competitors

Section 3 – Company Financial Performance Charts

Midatech Pharma Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Midatech Pharma Plc, Key Information
Midatech Pharma Plc, Key Ratios
Midatech Pharma Plc, Share Data
Midatech Pharma Plc, Major Products and Services
Midatech Pharma Plc, History
Midatech Pharma Plc, Key Employees
Midatech Pharma Plc, Key Employee Biographies
Midatech Pharma Plc, Key Operational Heads
Midatech Pharma Plc, Other Locations
Midatech Pharma Plc, Subsidiaries
Midatech Pharma Plc, Key Manufacturing facilities
Midatech Pharma Plc, Key Competitors
Midatech Pharma Plc, SWOT Analysis
Midatech Pharma Plc, Ratios based on current share price
Midatech Pharma Plc, Annual Ratios
Midatech Pharma Plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Midatech Pharma Plc, Performance Chart
Midatech Pharma Plc, Ratio Charts

★海外企業調査レポート[Midatech Pharma Plc (MTPH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Meyer Burger Technology AG (MBTN):電力:M&Aディール及び事業提携情報
    Summary Meyer Burger Technology AG (Meyer Burger) is a technology company that specializes in systems and processes based on semiconductor technologies. It provides technology, systems, machinery and processes for cutting and handling crystalline and other high-grade materials. It supplies ultra-thi …
  • RBS Wealth Management:企業の戦略・SWOT・財務情報
    RBS Wealth Management - Strategy, SWOT and Corporate Finance Report Summary RBS Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Beckman Coulter Inc:医療機器:M&Aディール及び事業提携情報
    Summary Beckman Coulter Inc (Beckman), is a subsidiary of Danaher Corp, is a manufacturer of biomedical testing instrument systems. It develops, manufactures and markets biomedical laboratory instruments, software and other things that simplify and automate complex biomedical tests. The company offe …
  • Fauji Fertilizer Bin Qasim Ltd (FFBL):電力:M&Aディール及び事業提携情報
    Summary Fauji Fertilizer Bin Qasim Ltd (FFBL) is a chemical manufacturing company that manufactures, supplies and markets di ammonium phosphate (DAP) and granular urea. In addition, the company undertakes production and marketing of ammonia and other nitrogenous fertilizers for agricultural applicat …
  • The Johnny Rockets Group, Inc.:企業の戦略・SWOT・財務情報
    The Johnny Rockets Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Johnny Rockets Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Klox Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Klox Technologies Inc (Klox Technologies) is a biomedical technology company that researches, develops and commercializes fluorescence biomodulation (FB) technology products for the treatment of skin and soft tissue disorders. The company develops FB systems to address conditions in the ther …
  • Graphic Packaging Holding Company:企業の戦略・SWOT・財務情報
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • BM-Bank Public Joint Stock Company:企業のM&A・事業提携・投資動向
    BM-Bank Public Joint Stock Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BM-Bank Public Joint Stock Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Garmin Ltd:企業の戦略・SWOT・財務情報
    Garmin Ltd - Strategy, SWOT and Corporate Finance Report Summary Garmin Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • CF Industries Holdings, Inc:企業のM&A・事業提携・投資動向
    CF Industries Holdings, Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CF Industries Holdings, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Ontario Power Generation Inc-エネルギー分野:企業M&A・提携分析
    Summary Ontario Power Generation Inc. (OPG) is an electricity generating company, fully owned by the Government of Ontario. It carries out the generation and sale of electricity in Ontario. The company generates electricity by utilizing various sources of energy including nuclear, hydroelectric, bio …
  • Alcon Laboratories Inc:製品パイプライン分析
    Summary Alcon Laboratories Inc (Alcon), a division of Novartis AG, develops and manufactures devices in the field of Ophthalmology. The company’s portfolio encompasses contact lenses and surgical products. Alcon’s products are used for the treatment of various conditions such as cataracts, glaucoma, …
  • Al Waha Capital P.J.S.C.:企業の戦略・SWOT・財務情報
    Al Waha Capital P.J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Al Waha Capital P.J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Multan Electric Power Company:企業の戦略的SWOT分析
    Multan Electric Power Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • PSE Kinsale Energy Ltd:企業の戦略的SWOT分析
    PSE Kinsale Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Cholamandalam Investment and Finance Company Ltd (CHOLAFIN):企業の財務・戦略的SWOT分析
    Cholamandalam Investment and Finance Company Ltd (CHOLAFIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the comp …
  • Patterson-UTI Energy, Inc.:企業の戦略・SWOT・財務情報
    Patterson-UTI Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Patterson-UTI Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Dover Corporation:企業の戦略・SWOT・財務分析
    Dover Corporation - Strategy, SWOT and Corporate Finance Report Summary Dover Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • SSBV-Rovsing A/S:企業の戦略・SWOT・財務情報
    SSBV-Rovsing A/S - Strategy, SWOT and Corporate Finance Report Summary SSBV-Rovsing A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bellicum Pharmaceuticals Inc (BLCM):企業の財務・戦略的SWOT分析
    Summary Bellicum Pharmaceuticals, Inc. (Bellicum) is a clinical stage biopharmaceutical company, which is engaged in developing cellular immunotherapies for the treatment of cancer. The company develops its product candidates through its chemical induction of dimerization technology platforms in the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆